Israel-based TytoCare has raised $11 million in Series B round led by Cambia Health Solutions. The company is also backed by major investors such as OrbiMed Advisors, Walgreens, Fosun Pharma and LionBird.

TytoCare makes a device that allows patients to perform a variety of examinations as part of a telehealth visit, all from the comfort of their own home. Using proprietary guidance and navigation technology, said device enables a layperson to collect and transmit high resolution digital images and video of the ear, nose, throat or skin, as well as lung and heart sounds. Additionally, TytoCare can capture and report vitals such as body temperature and heart rate.

On the other hand, there’s TytoCare’s cloud platform which provides secured communication, data repository, analytics and data sharing between patients, clinicians and healthcare organizations.

“TytoCare is addressing key limitations in the rapidly expanding use of telehealth for remote patient diagnosis of common acute problems,” said Dedi Gilad, TytoCare’s founder and CEO. “At present, the range of telehealth diagnoses is limited because clinicians must rely on phone or video conference only, without the benefit of vital clinical information provided by physical exam tools in the provider setting. TytoCare can remove these limitations with its connected examination technology.”